Novartis Gets US Approval for Menveo Meningitis Vaccine

Links shared publicly online about this topic.

  • 1,362
    total visits

Novartis Gets US Approval for Menveo Meningitis Vaccine

drugs.com

Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine) is used to prevent bacterial meningitis. Includes Menveo side effects, interactions and indications.

View full resource at drugs.com

Tags: Vaccination, Diphtheria, Meningitis, Vaccine, Novartis

  • Share

Most Recently Shared on February 23, 2010 at 12:40 am By:

drugscom Drugs.com

Novartis Gets US Approval for Menveo Meningitis Vaccine - http://bit.ly/a6Nnc1

2 years ago...

FDA chides Novartis on meningitis vaccine promotion | Reuters

reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 2, 2011 at 12:37 am By:

hrana Hisham Rana, MD Doctor and Physician

News: U.S. #FDA chides Novartis on meningitis vaccine promotion http://reut.rs/mUrVz7 - #health #pharma

10 months ago...

FDA chides Novartis on meningitis vaccine promotion

health.yahoo.net — “Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said in a letter to the Swiss drugmaker.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 9:40 pm By:

HealthSociety Healthy Society Health News

FDA chides Novartis on meningitis vaccine promotion http://bit.ly/lgB6bq

11 months ago...

FDA chides Novartis on meningitis vaccine promotion | Reuters

reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 9:32 pm By:

HealthNews2 Health News Health News

FDA chides Novartis on meningitis vaccine promotion: WASHINGTON (Reuters) - Novartis AG falsely im... http://bit.ly/jwdXTk #health #news

11 months ago...

FDA chides Novartis on meningitis vaccine promotion | Reuters

reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 9:31 pm By:

Reuters_Health Reuters Health Health News

FDA chides Novartis on meningitis vaccine promotion http://reut.rs/lMwrOq

11 months ago...

FDA chides Novartis on meningitis vaccine promotion

health.yahoo.net — “Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators said in a letter to the Swiss drugmaker.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 9:19 pm By:

FDA chides Novartis on meningitis vaccine promotion | Reuters

reuters.com — “WASHINGTON (Reuters) - Novartis AG falsely implied that its Menveo meningitis vaccine was approved in a manner consistent with guidelines from an influential U.S. advisory group, health regulators saidView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 8:34 pm By:

HITpol HealthIT Policy Health IT and Health News

FDA chides Novartis on meningitis vaccine promotion: WASHINGTON (Reuters) - Novartis AG falsely implied that its... http://bit.ly/mKoKzP

11 months ago...

UPDATE 1-Novartis to file meningitis vaccine for infants | Reuters

reuters.com — “* Study shows Menveo immunises infants from 2 months of age * Highest rate of infections occurs in first year of life (adds details, background) ZURICH, Oct 25 (Reuters) - Swiss drugmaker NovartisView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on October 25, 2010 at 11:51 am By:

JohnCFierce John Carroll Health Communicator

Big Phase III for meningitis vax comes in positive, Novartis says it is ready to file for approval in US/Europe. http://reut.rs/cO4KWp

2 years ago...

U.S. backs Novartis vaccine, MS drug wins priority | Reuters

reuters.com — “ZURICH (Reuters) - Novartis has won U.S. approval for its key Menveo meningococcal vaccine and got priority review for its oral treatment for multiple sclerosis (MS), underlining the promise of the SwissView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on February 22, 2010 at 2:00 pm By:

hrana Hisham Rana, MD Doctor and Physician

News: Novartis Gets FDA ok For Menveo (meningococcal vaccine), Priority Review For Gilenia (multiple sclerosis drug) http://bit.ly/b9MvVw

2 years ago...

U.S. backs Novartis vaccine, MS drug wins priority | Reuters

feeds.reuters.com — “ZURICH (Reuters) - Novartis has won U.S. approval for its key Menveo meningococcal vaccine and got priority review for its oral treatment for multiple sclerosis (MS), underlining the promise of the SwissView full resource at feeds.reuters.com

  • View Related
  • Share

Most Recently Shared on February 22, 2010 at 6:57 am By:

Advertisement